Larva currens following immunosuppressive treatment in an older patient with COVID-19 infection: a case report

The approach to diagnosis and treatment of COVID-19 infection has evolved through the years, and the use of immunosuppressive therapy is now increasingly mainstream. Simultaneously, we see a rise in reactivation of latent infections with such use of immunosuppressive therapy. We report a case of Strongyloides reactivation in the form of cutaneous Strongyloidiasis in a 77-year-old Singaporean Chinese woman, following treatment of COVID-19 pneumonia with a short course of dexamethasone. With the ease of availability and widespread use of immunosuppressants in COVID 19 infection, this case serves to remind us to have a high index of suspicion for reactivation of latent infections in the appropriate patient population.